Advanced search
Publication Cover
Epigenetics Volume 13, 2018 - Issue 4
Submit an article Journal homepage
1,479
Views
3
CrossRef citations to date
0
Altmetric
Meeting Report

Epigenetics of gastrointestinal diseases: notes from a workshop

David L. MarksSchulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USAView further author information
,
Rachel L. OlsonSchulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USAView further author information
,
Raul UrrutiaDivision of Research, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Daniel D. BilladeauSchulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USAView further author information
,
Nilotpal RoyDiabetes Center, University of California at San Francisco, San Francisco, CA, USAView further author information
,
George A. CalinDepartment of Experimental Therapeutics, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Muller FabbriChildren’s Center for Cancer and Blood Diseases, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USAView further author information
,
Marina KoutsioumpaLaboratory and the Center for Systems Biomedicine, University of California at Los Angeles, Los Angeles, CA, USAView further author information
,
Dimitrios IliopoulosLaboratory and the Center for Systems Biomedicine, University of California at Los Angeles, Los Angeles, CA, USAView further author information
,
Tamas OrdogDivision of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
Robert HuebertDivision of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0002-9812-7573View further author information
ORCID Icon,
Olga SarmentoDivision of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
Adebowale O. BamideleDivision of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0002-9547-2195View further author information
ORCID Icon,
William FaubionDivision of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
Gwen L. LomberkDivision of Research, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USAORCID Iconhttp://orcid.org/0000-0001-5463-789XView further author information
ORCID Icon,
Jens SivekeDivision of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, GermanyORCID Iconhttp://orcid.org/0000-0002-8772-4778View further author information
ORCID Icon,
Nita AhujaDepartment of Surgery, Yale School of Medicine, New Haven, CT, USAView further author information
,
Juan IovannaCentre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix Marseille, FranceORCID Iconhttp://orcid.org/0000-0003-1822-2237View further author information
ORCID Icon,
Ryan A. HladyDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USAView further author information
,
Keith RobertsonDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USAView further author information
,
John KisielDivision of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
Christopher L. PinDivision of Genetics & Development, Children’s Health Research Institute, Departments of Pediatrics, Physiology and Pharmacology, and Oncology, The University of Western Ontario, London, ON, CanadaView further author information
&
Martin E. Fernandez-ZapicoSchulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
View further author information
 show all
Pages 449-457 | Received 19 Jan 2018, Accepted 06 Apr 2018, Published online: 30 Jul 2018

References

  • Czaja AJ. Epigenetic changes and their implications in autoimmune hepatitis. Eur J Clin Invest. 2018 Jan 31;48:e12899. PubMed PMID: 29383703.
  • de Souza HSP, Fiocchi C, Iliopoulos D. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):739–749. PubMed PMID: 28831186.
  • Duell EJ. Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog. 2012 Jan;51(1):40–52. PubMed PMID: 22162230.
  • Kleeff J, Whitcomb DC, Shimosegawa T, et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017 Sep 7;3:17060. PubMed PMID: 28880010.
  • Ley D, Desseyn JL, Mischke M, et al. Early-life origin of intestinal inflammatory disorders. Nutr Rev. 2017 Mar 1;75(3):175–187. PubMed PMID: 28340001.
  • Moran-Salvador E, Mann J. Epigenetics and liver fibrosis. Cell Mol Gastroenterol Hepatol. 2017 Jul;4(1):125–134. PubMed PMID: 28593184; PubMed Central PMCID: PMCPMC5453904.
  • Reichert MC, Hall RA, Krawczyk M, et al. Genetic determinants of cholangiopathies: molecular and systems genetics. Biochim Biophys Acta. 2017 Jul 27. PubMed PMID: 28757171. DOI:10.1016/j.bbadis.2017.07.029
  • Robertson CC, Rich SS. Genetics of type 1 diabetes. Curr Opin Genet Dev. 2018 Feb 13;50:7–16. PubMed PMID: 29453110.
  • Webb GJ, Siminovitch KA, Hirschfield GM. The immunogenetics of primary biliary cirrhosis: A comprehensive review. J Autoimmun. 2015 Nov;64:42–52. PubMed PMID: 26250073; PubMed Central PMCID: PMCPMC5014907.
  • Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88–98. PubMed PMID: 29219149.
  • Grover M, Bernard CE, Pasricha PJ, et al. Diabetic and idiopathic gastroparesis is associated with loss of CD206-positive macrophages in the gastric antrum. Neurogastroenterol Motil. 2017 Jun;29(6). PubMed PMID: 28066953; PubMed Central PMCID: PMCPMC5423829. DOI:10.1111/nmo.13018
  • Hayashi Y, Toyomasu Y, Saravanaperumal SA, et al. Hyperglycemia increases interstitial cells of cajal via MAPK1 and MAPK3 signaling to ETV1 and KIT, leading to rapid gastric emptying. Gastroenterology. 2017 Aug;153(2):521–535 e20. PubMed PMID: 28438610; PubMed Central PMCID: PMCPMC5526732.
  • Ordog T, Takayama I, Cheung WK, et al. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes. 2000 Oct;49(10):1731–1739. PubMed PMID: 11016458.
  • Jalan-Sakrikar N, De Assuncao TM, Lu J, et al. Hedgehog signaling overcomes an EZH2-dependent epigenetic barrier to promote cholangiocyte expansion. PLoS One. 2016;11(12):e0168266. PubMed PMID: 27936185; PubMed Central PMCID: PMCPMC5148157. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
  • Luo CT, Liao W, Dadi S, et al. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016 Jan 28;529(7587):532–536. PubMed PMID: 26789248; PubMed Central PMCID: PMCPMC4978705.
  • Arvey A, van der Veeken J, Samstein RM, et al. Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells. Nat Immunol. 2014 Jun;15(6):580–587. PubMed PMID: 24728351; PubMed Central PMCID: PMCPMC4112080.
  • Xiong Y, Khanna S, Grzenda AL, et al. Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner. J Biol Chem. 2012 Oct 5;287(41):34372–34385. PubMed PMID: 22896699; PubMed Central PMCID: PMCPMC3464543.
  • Sarmento OF, Svingen PA, Xiong Y, et al. The role of the histone methyltransferase enhancer of Zeste Homolog 2 (EZH2) in the pathobiological mechanisms underlying Inflammatory Bowel Disease (IBD). J Biol Chem. 2017 Jan 13;292(2):706–722. PubMed PMID: 27909059; PubMed Central PMCID: PMCPMC5241744.
  • Iguchi E, Safgren SL, Marks DL, et al. Pancreatic cancer, a mis-interpreter of the epigenetic language. Yale J Biol Med. 2016 Dec;89(4):575–590. PubMed PMID: 28018146; PubMed Central PMCID: PMCPMC5168833.
  • Ribich S, Harvey D, Copeland RA. Drug discovery and chemical biology of cancer epigenetics. Cell Chem Biol. 2017 Sep 21;24(9):1120–1147. PubMed PMID: 28938089.
  • Artal-Martinez de Narvajas A, Gomez TS, Zhang JS, et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol. 2013 Oct;33(20):3983–3993. PubMed PMID: 23918802; PubMed Central PMCID: PMCPMC3811684.
  • Roy N, Malik S, Villanueva KE, et al. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev. 2015 Mar 15;29(6):658–671. PubMed PMID: 25792600; PubMed Central PMCID: PMCPMC4378197.
  • von Figura G, Fukuda A, Roy N, et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol. 2014 Mar;16(3):255–267. PubMed PMID: 24561622; PubMed Central PMCID: PMCPMC4684081.
  • Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1. PubMed PMID: 28694740; PubMed Central PMCID: PMCPMC5490340.
  • Rigoutsos I, Lee SK, Nam SY, et al. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. 2017 May 24;18(1):98. PubMed PMID: 28535802; PubMed Central PMCID: PMCPMC5442648.
  • Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA. 2012 Jul 31;109(31):E2110–6. PubMed PMID: 22753494; PubMed Central PMCID: PMCPMC3412003.
  • Challagundla KB, Wise PM, Neviani P, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015 Jul;107(7). PubMed PMID: 25972604; PubMed Central PMCID: PMCPMC4651042. DOI:10.1093/jnci/djv135
  • Tallen G, Riabowol K. Keep-ING balance: tumor suppression by epigenetic regulation. FEBS Lett. 2014 Aug 19;588(16):2728–2742. PubMed PMID: 24632289.
  • Mathison A, Salmonson A, Missfeldt M, et al. Combined AURKA and H3K9 methyltransferase targeting inhibits cell growth by inducing mitotic catastrophe. Mol Cancer Res. 2017 Aug;15(8):984–997. PubMed PMID: 28442587; PubMed Central PMCID: PMCPMC5705946.
  • Mazur PK, Herner A, Mello SS, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015 Oct;21(10):1163–1171. PubMed PMID: 26390243; PubMed Central PMCID: PMCPMC4959788.
  • Abdelfatah E, Kerner Z, Nanda N, et al. Epigenetic therapy in gastrointestinal cancer: the right combination. Therap Adv Gastroenterol. 2016 Jul;9(4):560–579. PubMed PMID: 27366224; PubMed Central PMCID: PMCPMC4913338.
  • Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47–52. PubMed PMID: 26909576.
  • Birnbaum DJ, Finetti P, Birnbaum D, et al. Validation and comparison of the molecular classifications of pancreatic carcinomas. Mol Cancer. 2017 Nov 6;16(1):168. PubMed PMID: 29110659; PubMed Central PMCID: PMCPMC5674743.
  • Collisson EA, Sadanandam A, Olson P, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011 Apr;17(4):500–503. PubMed PMID: 21460848; PubMed Central PMCID: PMCPMC3755490.
  • Nicolle R, Blum Y, Marisa L, et al. Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts. Cell Rep. 2017 Nov 28;21(9):2458–2470. PubMed PMID: 29186684.
  • Kisiel JB, Raimondo M, Taylor WR, et al. New DNA methylation markers for pancreatic cancer: discovery, tissue validation, and pilot testing in pancreatic juice. Clin Cancer Res. 2015 Oct 1;21(19):4473–4481. PubMed PMID: 26023084; PubMed Central PMCID: PMCPMC4592385.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.